Cannapharmarx Return on Equity (ROE) Growth & History (CPMD)

Cannapharmarx's return on equity was 142.10% for fiscal 2023.

View full Cannapharmarx company overview

Cannapharmarx annual return on equity history

Cannapharmarx annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20232023-12-31142.10%+528.25 pp
20222022-12-31−386.15%
20192019-12-31−895.43%

Cannapharmarx return on equity trends

Between the periods ended 2019-12-31 and 2023-12-31, Cannapharmarx's return on equity increased from −895.43% to 142.10%, a change of +1037.53 percentage points. The latest reported quarter, Q4 2022, shows −308.46%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cannapharmarx source filings ↗

Community posts

It’s quiet here.

No posts about CPMD yet. Start the conversation.

Write the first post